Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute haematogenous osteomyelitis

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Sepsis, abscess and threatened growth cannot wait

Acute haematogenous osteomyelitis can progress from focal metaphyseal infection to bacteraemia, subperiosteal or intramuscular abscess, septic arthritis and physeal injury before early radiographs become abnormal.

Action: Admit under paediatric and orthopaedic teams, assess for sepsis and every adjacent joint, obtain blood cultures and essential blood tests promptly, start empirical intravenous antibiotics immediately when high-risk sepsis criteria are met, and obtain urgent imaging and drainage when abscess, joint infection or deterioration is suspected.

Synopsis

Recognise blood-borne bone infection early, distinguish a stable child from sepsis or a drainable focus, obtain meaningful cultures, and coordinate antibiotics, imaging, source control and growth-aware follow-up.

  • A limping, non-weight-bearing or pseudoparalysed child with focal bone tenderness and fever has osteomyelitis until a safer explanation is established; early skin and radiographs may look normal.
  • Admit all children with suspected acute musculoskeletal infection for combined paediatric and orthopaedic care and examine the whole child, spine and adjacent joints.
  • Initial investigations are FBC, CRP, blood cultures and ESR in the BOASt sequence, plus plain radiographs of the relevant bone and joint; no single result excludes disease.
  • MRI is the preferred second-line modality, ideally within 48 hours, and sooner when deterioration or a deep collection is suspected; ultrasound helps identify an effusion or superficial collection.
  • Give empirical intravenous antibiotics immediately in high-risk sepsis. If stable and surgery is planned promptly, senior teams may defer antibiotics briefly to obtain deep samples.
  • First-line treatment of uncomplicated acute osteomyelitis is intravenous antibiotics; abscess, septic joint, necrotic tissue or poor response creates a drainage or debridement question.
  • Use clinical recovery and serial temperature, CRP, ESR and white-cell trends to decide intravenous-to-oral switch and total course with microbiology, not an isolated normal value.
  • Follow clinically and radiographically for at least 12 months with expertise able to recognise recurrent infection, physeal arrest, deformity and functional loss.

Key red flags

Shock, altered behaviour, mottling, oliguria, rising lactate or rapidly worsening limb pain indicates systemic danger and requires parallel sepsis treatment and orthopaedic source-control planning.

A painful immobile joint beside the affected metaphysis, especially the hip or shoulder where the metaphysis may lie within the capsule, raises concern for associated septic arthritis requiring urgent drainage.

Fluctuance, marked swelling, persistent fever or failure of CRP and symptoms to improve after appropriate therapy suggests a subperiosteal, soft-tissue or intraosseous collection.

Back pain, neurological deficit, multifocal tenderness, chest symptoms or a new murmur suggests vertebral, multifocal, pulmonary or endovascular spread and widens imaging and specialist assessment.

Investigation priorities

01
Initial FBC and CRPFirst step

Assess inflammation, cytopenia and a baseline for response.

02
Preferred second-line MRIPreferred

Map marrow, cortex, physis, joint and soft-tissue extension.

Management branches

UnstableTreat sepsis while defining source

High-risk sepsis, organ dysfunction or rapid clinical decline accompanies suspected bone infection.

  1. Call paediatrics, orthopaedics, anaesthesia and microbiology and apply the current sepsis pathway without waiting for imaging.
  2. Take blood cultures and essential tests immediately, then give empirical intravenous antibiotics with no avoidable delay.
  3. Image urgently enough to find septic joint, abscess or another focus and move directly to drainage when indicated.
  4. Reassess perfusion, lactate, urine output, pain and all potential metastatic sites through resuscitation and source control.
StablePreserve culture and map anatomy

The child is physiologically stable and definitive sampling or surgery can occur promptly.

  1. Complete paediatric and orthopaedic examination, FBC, CRP, blood cultures, ESR and plain radiographs.
  2. Arrange preferred MRI and ultrasound within 48 hours or sooner according to pain, site and clinical trajectory.
  3. If theatre is planned, make an explicit senior decision whether a short antibiotic delay safely improves deep-sample yield.
  4. Start policy-based intravenous therapy after samples and tailor promptly to culture, allergy, weight and organ function.

Key medicines

Empirical intravenous therapy for paediatric bone infectionUse the trust's current paediatric bone-and-joint infection regimen at the full weight-based dose immediately after blood cultures in high-risk sepsis; in a stable child, start immediately after planned deep sampling and record dose, interval and review time.Selection varies with age, allergy, renal function, local MRSA prevalence, sickle-cell disease, water or animal exposure and prior antibiotics; involve paediatric infection specialists early and never let drug preparation delay drainage of a septic joint or abscess.
Culture-directed oral continuationWhen the child is clinically improving, inflammatory trends are favourable, oral absorption is reliable and an active formulation is available, prescribe the exact weight-based oral agent and frequency agreed with microbiology for the documented remaining course and review date.Check palatability, maximum adult dose, interactions, allergy, renal or hepatic adjustment and family ability; recurrence of fever, pain or poor use requires urgent reassessment rather than automatic extension.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BOASt - The Management of Children with Acute Musculoskeletal Infection
  • NICE NG253 - Managing suspected sepsis
  • NHS Osteomyelitis
  • NICE CKS Osteomyelitis

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom